We are happy to announce that the second Core HTA produced within the EUnetHTA Joint Action 2 Work Package 4 is available for public feedback. The topic assessed is “Use of Intravenous immunoglobulins for Alzheimer’s disease including Mild Cognitive Impairment”
We are pleased to announce that as of today the Draft Project Plan “Endovascular therapy using mechanical thrombectomy devices for acute ischaemic stroke”, produced within WP5 Strand B, has entered the public consultation phase.
We are starting to provide links to the EUnetHTA partners’ Annual Reports. The links could be found via the individual profiles of the partner organisations that can be found via the Contact page.
We are pleased to announce that the 4th pilot rapid assessment of WP5 JA2 Strand B on “Biodegradable stents for the treatment of refractory or recurrent benign oesophageal stenosis” is now available.
In order to gather as much feedback as possible, WP7 Subgroup 2 has decided to extend the public consultation period on the Position paper on how to decide on the appropriate study design until May 29, 2015 at 12:00 noon CET.